Skip to content

Exagen Inc. XGN Interest Paid

Interest Paid at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$22.4M+0.9%
Revvity logo
RevvityRVTY
$21.55M-5.4%
Agilent Technologies logo
Agilent TechnologiesA
$44M-8.3%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$1.62M+17.7%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s interest paid?
Exagen Inc. (XGN) reported interest paid of $856K in Q1 2026.
How has Exagen Inc.'s interest paid changed year-over-year?
Exagen Inc.'s interest paid increased by 112.9% year-over-year, from $402K to $856K.
What is the long-term trend for Exagen Inc.'s interest paid?
Over 4 years (2021 to 2025), Exagen Inc.'s interest paid has grown at a 13.3% compound annual growth rate (CAGR), from $1.82M to $2.99M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.